In the current study, given previous documentation of anti-inflammatory and anti-fibrotic characteristics of FTS, the role of Ras and the therapeutic potential of FTS was evaluated in this mouse model of merosin deficient congenital muscular dystrophy. This evidence concerns the gene AKTIP and congenital muscular dystrophy due to LMNA mutation.